Francisco Salva is the founder of Azitra. Latest round: Growth. Backed by Bios Partners. Based in Branford, Connecticut.
Francisco Salva is the President and CEO of Azitra Inc., a clinical-stage biopharmaceutical company focused on precision dermatology using engineered proteins and live biotherapeutic products. Under his leadership in 2025, Azitra progressed three programs, dosed the first patient in a Phase 1/2 trial for ATR-04, and raised $2.8M via an equity line. He is based in Branford, Connecticut, where the company is headquartered.
Full founder directory · Investor directory · Company funding database · Fundraising library